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Abstract
Near-infrared (NIR) optical imaging is a noninvasive and nonionizing modality that is emerging as a diagnostic tool
for breast cancer. The handheld optical devices developed to date using the NIR technology are predominantly
developed for spectroscopic applications. A novel handheld probe–based optical imaging device has been recently
developed toward area imaging and tomography applications. The three-dimensional (3D) tomographic imaging
capabilities of the device have been demonstrated from previous fluorescence studies on tissue phantoms. In
the current work, fluorescence imaging studies are performed on tissue phantoms, in vitro, and in vivo tissue mod-
els to demonstrate the fast two-dimensional (2D) surface imaging capabilities of this flexible handheld-based
optical imaging device, toward clinical breast imaging studies. Preliminary experiments were performed using tar-
get(s) of varying volume (0.23 and 0.45 cm3) and depth (1-2 cm), using indocyanine green as the fluorescence
contrast agent in liquid phantom, in vitro, and in vivo tissue models. The feasibility of fast 2D surface imaging
(∼5 seconds) over large surface areas of 36 cm2 was demonstrated from various tissue models. The surface
images could differentiate the target(s) from the background, allowing a rough estimate of the target’s location
before extensive 3D tomographic analysis (future studies).
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Introduction
Handheld-based optical imaging devices have been developed for
breast imaging to accelerate the clinical translation of the technology
toward cancer diagnosis. Several of these handheld devices have been
tested in vivo on human subjects [1 2 3 4 5, selected publications].
However, they are unable to contour to the curvature of human
breast tissue because all these devices used flat-probe faces. The pre-
dominant applications to date have been either toward spectroscopic
measurement of tissue optical properties or two-dimensional (2D)
localization studies of abnormal tissue within the breast. Recently,
a handheld optical imaging device has been developed in our Optical
Imaging Laboratory [6] toward imaging large tissue surfaces using a
flexible probe face that contours to different tissue curvatures. The
device is intended to augment current clinical imaging modalities
for breast cancer detection and diagnosis. The three-dimensional
(3D) tomographic ability of the device has been demonstrated on
large tissue phantoms using a fluorescence-enhanced–based imaging
technique [7]. Herein, preliminary studies are performed on tissue
phantoms, in vitro, and in vivo tissue models to demonstrate the fast
2D surface imaging capabilities of this flexible handheld-based opti-
cal imaging device toward clinical breast imaging studies.
Materials and Methods
Instrumentation
The instrumentation for the handheld optical imaging device con-
sists of a 785-nm, 500-mW laser diode source and an intensified
charge-coupled device (ICCD) camera detector (with 550-850 nm
bandwidth at the intensifier end) as shown in Figure 1. The source
light is launched onto and collected from the tissue surface using a
handheld-based probe head (4 × 9-cm2 imaging area). The handheld
probe consists of 6 points of illumination and 165 points of collec-
tion (as shown in Figure 2) of optical signals through optical fibers,
which connect the probe head to the source and detector. The total
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laser power incident on the phantom or tissue is <10 mW. The de-
vice has a flexible probe head design such that it contours to different
tissue curvatures during imaging. Simultaneous illumination and de-
tection from multiple point locations is carried out to reduce the
overall imaging time. Additional details of the instrumentation are
provided elsewhere [7]. The instrumentation is developed such that
it can acquire both continuous wave (CW)–based and frequency-
domain–based optical measurements as required. To facilitate 2D
imaging in real time, the device was operated in the CW mode for
the current study in tissue phantoms, in vitro, and in vivo.
Data Acquisition and Analysis
Two-dimensional surface imaging was performed, using the hand-
held device operated in the CWmode, on tissue phantoms, in vitro,
and in vivo tissue models. In all cases, fluorescence-enhanced imaging
was performed using an external fluorescing agent indocyanine green
(ICG) for improved contrast. Spherical acrylic targets (of different
sizes) filled with 1 μM ICG were used to mimic a tumor. The target
was placed at different depths from the imaging surface and different
target-to-background (T:B) contrast ratios (1:0 and 100:1) were used
for different experimental cases. The probe was placed in contact
with the phantom or tissue surface as shown in Figure 3, and CW
images of the fluorescent intensity were acquired in close to real time
(∼2 seconds’ delay). The raw fluorescence intensity images at the
ICCD camera end were acquired in 1 second (0.2-second exposure
time × 5 repetitions). These images were postprocessed (∼1 second)
using in-house developed Matlab codes to acquire the final 2D sur-
face contour plots of fluorescence intensity distribution of the imaged
surface. The entire data acquisition and postprocessing were auto-
mated such that close to real-time (∼2 seconds’ delay) imaging is pos-
sible. The 2D surface contour plots of fluorescence intensity signal
may or may not differentiate the target from the tissue phantom
background, based on the target and background optical properties.
During fluorescence optical imaging, the output signal at the tis-
sue surface is a mixture of fluorescence signal and the attenuated in-
cident near-infrared (NIR) (i.e., excitation) signal. This fluorescence
signal is filtered from the strong excitation signal (three to four orders
of magnitude higher) using appropriate optical (band-pass) filters and
imaged by the detector. However, the filters are not capable of 100%
rejection of the excitation light, causing an excitation leakage and
contamination of the fluorescent signal. Hence, a second level of
postprocessing is carried out to subtract a background nonfluorescing
image from the final fluorescence image plots for each experimental
case to account for the excitation leakage. Initially, optical measure-
ments were acquired before placing the fluorescent target in the
phantom, in an attempt to represent the excitation leakage (or back-
ground noise). These (background noise) measurements were sub-
tracted from the fluorescence optical measurements obtained from
experimental cases that included fluorescent targets to effectively
eliminate the signal from the excitation source light. In the clinical
setting involving actual diseased tissues (unlike the simulated fluores-
cent targets in the current study), this could be accomplished by ac-
quiring image(s) of the tissue before and after the contrast agent (e.g.,
ICG) injection. The nonfluorescent image(s) acquired before ICG
injection will in turn be subtracted from the fluorescent images ac-
quired after ICG injection to account for the background noise.
The subtracted 2D fluorescence images are generated rapidly (<5 sec-
onds), making the entire process a fast 2D surface imaging tech-
nique. The acquisition of these subtracted fluorescence 2D surface
contour plots has greater significance in 2D target localizations as
well as in 3D tomographic imaging studies.
Experimental Cases
Tissue phantom studies. Studies were performed using slab tissue
phantoms composed of 10 × 10 × 10-cm3 acrylic cubes filled with
650 ml of 1% Liposyn solution (Liposyn II, 20%; Henry Schein,
Melville, NJ) to mimic the optical properties of a typical breast tissue.
The fluorescent target was placed at different depths (1.5-2.5 cm) from
Figure 1. Handheld probe–based optical imaging system showing the handheld probe is fiber-optically coupled to the laser source and
ICCD camera (left). The probe face is flexible to contour to different tissue curvatures (right).
Figure 2. Picture of the handheld probe face showing the source-
detector configuration. The large red dots represent the six source
fiber locations, and all other small holes are the 165 detector fi-
ber locations.
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the imaging surface and real-time as well as fast (subtracted) images of
fluorescence intensity were acquired. The different experimental cases
are summarized in Table 1.
In vitro phantom studies. Before in vivo studies with human sub-
jects, experiments were performed using in vitro phantoms, which
were composed of minced chicken breast combined with 1% Liposyn
solution, to introduce a nonuniform scattering background. The
in vitro mixture of minced chicken breast (480 ml) and 1% Liposyn
(260 ml) was placed inside a 10 × 10 × 10-cm3 acrylic cube. Real-
time as well as fast (subtracted) images of fluorescence intensity
were acquired under different experimental conditions using either
a 0.23-cm3 or 0.45-cm3 fluorescent target located at various depths
between 1 and 2 cm (Table 1).
In vivo studies. In vivo studies were performed on healthy human
subjects to demonstrate the feasibility of using the handheld device to
collect images of a fluorescent target with a background of real hu-
man breast tissue. All human subject studies were approved by the
Florida International University Institutional Review Board. Healthy
female volunteers aged 21 and older were recruited for the studies. A
fluorescent target was used to simulate a tumor (as described in Data
Acquisition and Analysis) and was placed underneath the flap of the
breast tissue (i.e. between breast tissue and chest wall, underneath the
tissue). In the first study, a 0.23-cm3 sphere with 1 μM ICG was
placed under the right breast in the 4-o’clock position. The flat-probe
face was placed against the breast tissue with gentle compression, and
a real-time fluorescent intensity image was acquired (around the tar-
get region). The depth of the target within the tissue was approxi-
mately 2.5 cm as measured with a vernier caliper.
A second study was performed using a single target with the probe
in the maximum curved position (i.e., 45° curvature of the two side
plates of the three-plate–based probe face). The images collected with
the probe in the curved position possibly include transilluminated
measurements in addition to reflectance-based measurements. This
study was performed to demonstrate the feasibility of using the probe
Figure 3. Experimental setup for tissue phantom, in vitro, and in vivo studies: (A) empty phantom showing target inclusion and place-
ment of probe, (B) tissue slab phantom with 1% Liposyn solution for uniform scattering in the background, (C) in vitro slab phantom with
heterogeneous scattering in the background, and (D) setup for in vivo studies using mannequin (for demonstration only) to represent
human subject.
Table 1. Summary of Experimental Cases for Slab Tissue Phantom, In Vitro, and In Vivo Studies.
Subject Studied Experiment No. Number of Targets Target Depth (cm) Target Volume (cm3) T:B Contrast Ratio
Slab tissue phantom (uniform scattering in background) 1 1 1.5 0.45 1:0
2 1 2.0 0.45 1:0
3 1 2.5 0.45 1:0
In vitro phantom (nonuniform scattering in background) 4 1 1.0 0.45 1:0
5 1 1.5 0.45 1:0
6 1 2.0 0.45 1:0
7 1 1.0 0.23 1:0
8 1 1.5 0.23 1:0
9 1 2.0 0.23 1:0
In vitro with healthy human subject 10 1 2.5 0.23 1:0
11 1 2.5 0.45 1:0
12 2 2.5 0.23 and 0.45 1:0
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in its curved position, such that it can contour along the tissue and
also provide fluorescent images that can aid in target detection. Herein,
a 0.45-cm3 fluorescent target containing 1 μM ICG was placed under
the right breast in the 8-o’clock position. A real-time as well as fast
(subtracted) image of fluorescence intensity was acquired by applying
gentle compression along the tissue curvature.
A third study was performed to demonstrate the feasibility of imag-
ing multiple targets within real human breast tissue. Two targets were
placed under the fold of the left breast tissue, with a 0.23-cm3 target
at the 6-o’clock position, and a 0.45-cm3 target was placed at the
8-o’clock position of the same breast. A real-time as well as fast (sub-
tracted) image of fluorescence intensity was acquired by applying gen-
tle compression on the left breast tissue.
All these preliminary in vivo studies used micromolar concentra-
tions of ICG in the tumor-mimicking target(s), similar to the current
tissue phantom, in vitro phantom studies, and also that used by other
researchers [7–9]. The actual in vivo studies on breast cancer subjects
cannot estimate the concentration of ICG (after injection) at the
tumor site, and the researchers typically report the injected quantities
of the contrast agent [8,10].
Results
Tissue Phantom Studies
Real-time images using the slab phantom with uniform scattering
in the background are shown in Figure 4 as 2D surface contour plots
of the fluorescence intensity data with a target placed at different
depths (1.5-2.5 cm) from the imaging surface. The nonuniform in-
tensity distribution in Figure 4 is possibly due to the residual exci-
tation leakage around the six source fibers (after the implementation
of the subtraction technique). In addition, the input laser source sig-
nal is not evenly distributed among the six source fibers, possibly
causing a variation or nonuniformity in the output fluorescence in-
tensity distribution.
The images show the feasibility of performing (close to) real-time
2D imaging using the handheld device in tissue phantoms. The ac-
tual target location in the images is indicated in the figures by the
black open circle in the x-y plane for different target depths in the
“z” direction. The fast 2D image estimates the 2D target location
(instantly) in the x-y plane. This information can then be further
used toward 3D tomography (in the future) to determine the tumor
volume, location, and depth [9].
From these plots, it is obvious that the real-time images are capable
of differentiating the target from the background when the 0.45-cm3
target was 1.5 cm deep. At greater tissue depths, the target was not
distinctly differentiable because of the strong excitation leakage from
the background. On applying the subtraction technique (as described
in Data Acquisition and Analysis), the target is clearly differentiable
from the background in all the experimental cases (Figure 5). These
subtracted images also have potential to obtain 3D target localiza-
tion through tomographic imaging, as long as the probe’s location
on the tissue surface is coregistered with respect to the surface fluo-
rescence images.
In Vitro Phantom Studies
The results for the in vitro phantom experiments are shown in Fig-
ures 6 (real-time images) and 7 (fast subtracted images) for different
target depths (1-2 cm) under a T:B contrast ratio of 1:0. The true
Figure 4. Near real-time images of fluorescence intensity obtained as 2D surface contour plots acquired from slab phantoms (with
uniform background scattering). The fluorescent target was placed at different locations and depths: (A) target location (x,y,z) =
(2.0, 2.7, 1.5), and (B) target location (x,y,z) = (2.0, 2.7, 2.0), and (C) target location (x,y,z) = (3.0, 2.2, 2.5). The black hollow circle in
each subplot is the true target location.
Figure 5. Fast subtracted images of fluorescence intensity obtained as 2D surface contour plots acquired from slab phantoms (with
uniform background scattering). The 0.45-cm3 fluorescent target was placed at different locations and depths: (A) target location (x,y,z) =
(2.0, 2.7, 1.5), and (B) target location (x,y,z) = (2.0, 2.7, 2.0), and (C) target location (x,y,z) = (3.0, 2.2, 2.5). The black hollow circle in each
subplot is the true target location.
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target location in the images is given as x,y,z coordinates where “x” is
the lateral position, “y” is the height, and “z” is the depth that vary
among the images. Owing to heterogeneous scattering of the back-
ground phantom, only the subtracted images were capable of clearly
differentiating the target from the background for targets deeper than
1.0 cm. These studies show the ability of the handheld device to per-
form fast 2D surface imaging and target localization within a non-
uniform scattering tissue-mimicking background.
In Vivo Studies
Figure 8 shows the fast 2D subtracted images of fluorescence in-
tensity obtained in vivo (from a healthy human subject using a sim-
ulated target) with the probe in the flat position (Figure 8A) and in
the curved position (Figure 8B). These subtracted image results dem-
onstrate the feasibility of fast 2D surface imaging and 2D target lo-
calization in a clinical environment. The real-time (nonsubtracted)
images of fluorescence intensity were unable to differentiate the tar-
get from the heterogeneous background, and hence, only the fast 2D
subtracted images are shown in Figure 8.
The 2D subtracted images of fluorescent intensity from multiple
simulated targets in a human subject are shown in Figure 9. The
0.23-cm3 target is detected in the center of the image and the
0.45-cm3 target is detected toward the left side in the image, which
are very close to the true locations of these targets. This study dem-
onstrates the potential to image and localize multiple fluorescent tar-
gets (of different sizes) within human breast tissue.
Discussion
The fluorescence imaging studies described here demonstrate for the
first time the acquisition of fast 2D surface images (in <5 seconds) of
a fluorescent target in uniform tissue phantoms, in vitro, and in vivo
using a handheld-based optical imaging device. The subtracted im-
ages have a potential to clearly differentiate target(s) from the back-
ground (under various experimental conditions), demonstrating the
potential to translate the technology toward on-site breast imaging in
a clinical environment. Additional experiments were performed with
the target located at greater depths in the tissue phantoms, but the
target was not detected at a depth of 2.5 cm. At 2.5 cm deep, the
Figure 6. Near real-time images of fluorescence intensity obtained as 2D surface contour plots acquired from in vitro slab phantoms
(with nonuniform background scattering). The 0.45-cm3 fluorescent target was located at a depth of (A) 1.0 cm and (B) 1.5 cm from the
imaging surface. The black hollow circle in each subplot is the true target location.
Figure 7. Fast subtracted images of fluorescence intensity obtained as 2D surface contour plots acquired from in vitro slab phantoms
(with nonuniform background scattering). Images were collected for different target sizes and depths. Images (A) to (C) contain a target
size of 0.45 cm3 at depths of 1.0, 1.5, and 2.0 cm, respectively. Images (D) to (F) contain a target size of 0.23 cm3 at depths of 1.0, 1.5,
and 2.0 cm, respectively. The black hollow circle in each subplot is the true target location.
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detected signal from the target is close to the noise floor and hence
not differentiable from the background. A multilocation scanning ap-
proach is currently developed in our laboratory for differentiating
deeply located or small-volume targets from homogenous or hetero-
geneous background [11]. In short, this approach will incorporate
the use of coregistered images obtained at multiple locations on
the tissue surface, such that the targets can be differentiated from
artifacts as well as the background [11]. When comparing Figures 4
and 5, it can be seen that the images from the in vitro phantom con-
tain more noise than those from the uniform tissue phantom. This
can possibly be attributed to the heterogeneous distribution of scat-
tering properties or shifting of the chicken breast as the target is re-
moved (which can cause a change in the signal distribution when the
background image is collected). Experiments were also performed
using the in vitro phantoms with a T:B contrast ratio of 100:1. How-
ever, the noise from the background signal dominated the image, and
a target was not detected even after subtracting the excitation back-
ground signal. On applying our multilocation scanning approach,
the targets were differentiable under imperfect uptake conditions
(i.e., T:B = 100:1) [11]. In addition to fast 2D imaging, the handheld
device described here has demonstrated 3D tomography of fluores-
cent targets with tissue phantoms using frequency-domain–based
measurements to estimate the 3D location and volume of the target
within the tissue [9]. Our ongoing efforts will involve the implemen-
tation of fast and automated coregistration facilities to enable precise
2D target localization (instantaneously) as well as 3D tomography
studies (in vitro as well as in vivo).
Conclusions
A handheld-based optical imaging device has been developed in our
Optical Imaging Laboratory toward in vivo clinical studies on breast
Figure 8. Fast subtracted images of fluorescence intensity obtained as 2D surface contour plots, acquired in vivo from a human subject
using a spherical fluorescent target, for two experimental cases: (A) the probe was in the flat position and a 0.23-cm3 target was placed
at the 4-o’clock position; and (B) the probe was in the curved position and a 0.45-cm3 target was placed at the 8-o’clock position. The
images acquired using the probe in the curved position are illustrated as projected as a flat 2D image to be consistent with the images
presented in case (A) (i.e., using the probe in flat position).
Figure 9. Fast subtracted image of fluorescence intensity obtained as 2D surface contour plot acquired in vivo from a human subject
using two spherical fluorescent targets (0.23 and 0.45 cm3).
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tissues. The device has been tested extensively in the past on homo-
geneous slab phantoms (with sample results shown here). The device
has been tested for CW-based fluorescence optical imaging in vitro as
well as in vivo. The fluorescence studies demonstrate the ability of the
handheld device to perform fast 2D imaging and also detect a fluores-
cent target within a heterogeneous tissue-mimicking background as
well as real human breast tissue (on using subtracted images). Future
work will involve fast coregistered imaging of human breast tissue to
enable 3D tomography in human subjects using this novel handheld-
based optical device.
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